HOME › DRUGS › DASATINIB
ACTIVE SUBSTANCE / INN

DASATINIB

Brand name(s): Dasatinib Accord Healthcare, SPRYCEL, PHYRAGO, DASATINIB
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Mye…
ANDA203180
ACTIVE SUBSTANCE
Dasatinib
REGULATORS
FDA · EMA
SPONSORS / MAH
BRISTOL MYERS SQUIBB, HANDA THERAP, APOTEX
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DASATINIBANDA203180APOTEXPrescription
SPRYCELNDA021986BRISTOL MYERS SQUIBBPrescription
PHYRAGONDA216099HANDA THERAPPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Dasatinib Accord HealthcareAccord Healthcare S.L.U.Authorised26/07/2024Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, B…

FULL INTELLIGENCE ON DASATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →